IRIS - Res&Arch Institutional Research Information System - Research & Archive

BORDONI, Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.431
AS - Asia 1.012
EU - Europa 690
SA - Sud America 125
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 20
OC - Oceania 5
Totale 3.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.359
SG - Singapore 436
IT - Italia 231
CN - Cina 149
HK - Hong Kong 113
RU - Federazione Russa 101
IE - Irlanda 94
VN - Vietnam 92
BR - Brasile 90
BD - Bangladesh 69
DE - Germania 62
FR - Francia 46
CA - Canada 43
KR - Corea 38
IN - India 25
GB - Regno Unito 23
FI - Finlandia 21
NL - Olanda 20
MX - Messico 16
PL - Polonia 16
AT - Austria 15
TR - Turchia 14
IQ - Iraq 13
ES - Italia 11
BE - Belgio 10
JP - Giappone 10
UA - Ucraina 10
AR - Argentina 9
PK - Pakistan 9
SE - Svezia 9
EC - Ecuador 8
ID - Indonesia 8
ZA - Sudafrica 7
SA - Arabia Saudita 6
CO - Colombia 5
CR - Costa Rica 4
IL - Israele 4
VE - Venezuela 4
AU - Australia 3
BO - Bolivia 3
KW - Kuwait 3
MA - Marocco 3
RO - Romania 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AI - Anguilla 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
YT - Mayotte 1
Totale 3.283
Salva come PNG Salva come JPEG
Città #
Singapore 348
San Jose 169
Ashburn 148
Chandler 130
Hong Kong 113
Dublin 90
Perugia 84
Santa Clara 57
Council Bluffs 51
Los Angeles 43
Moscow 40
Seoul 38
New York 37
Munich 36
Boardman 35
Ann Arbor 34
Beijing 30
Lauterbourg 29
San Mateo 28
Dong Ket 21
Princeton 20
Hanoi 18
Piscataway 18
Ho Chi Minh City 17
Milan 17
Medford 16
Altamura 15
Warsaw 15
Brooklyn 13
Phoenix 13
Toronto 13
Dallas 12
Turku 12
Rome 11
The Dalles 11
Wilmington 11
Amsterdam 10
Brussels 10
Buffalo 10
Lawrence 10
Montreal 10
São Paulo 10
Tokyo 10
Hefei 9
Redwood City 9
Denver 8
Baghdad 7
Charlotte 7
Nuremberg 7
Vicenza 7
Vienna 7
Atlanta 6
Chicago 6
Florence 6
Frankfurt am Main 6
Helsinki 6
Naples 6
Orem 6
San Francisco 6
Stockholm 6
Andover 5
Houston 5
Mexico City 5
New Orleans 5
Poplar 5
Quito 5
Saint Petersburg 5
Seattle 5
Bologna 4
Den Haag 4
Des Moines 4
Gualdo Cattaneo 4
Miami 4
Querétaro 4
San José 4
Ankara 3
Calgary 3
Cambridge 3
Can Tho 3
Chennai 3
Columbus 3
Hải Dương 3
Istanbul 3
Jeddah 3
Lahore 3
Lappeenranta 3
London 3
Manchester 3
Mumbai 3
New Delhi 3
North Bergen 3
Riverbank 3
San Diego 3
Secaucus 3
Shanghai 3
Sydney 3
Turin 3
Vancouver 3
Zhengzhou 3
Abidjan 2
Totale 2.120
Salva come PNG Salva come JPEG
Nome #
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 124
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 124
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 122
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 115
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 115
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 113
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 110
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 109
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 109
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 107
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 104
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 103
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 102
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 101
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 100
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 99
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 96
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 95
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 95
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 93
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 93
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 91
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 89
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 89
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 88
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 83
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 83
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 82
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 81
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 77
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 74
Modeling Inflammatory Bowel Disease by Intestinal Organoids 73
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 66
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 62
Dysregulated Lipid and Protein Networks in Osteochondrosis 49
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer 36
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy 13
Totale 3.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022101 0 0 0 5 1 1 13 24 2 16 13 26
2022/2023388 27 60 4 32 39 43 0 17 143 1 14 8
2023/2024195 8 17 3 5 12 1 51 26 17 8 26 21
2024/2025646 7 41 29 40 41 60 51 69 133 29 93 53
2025/20261.507 93 98 74 202 220 118 212 69 139 133 71 78
2026/2027371 39 62 70 200 0 0 0 0 0 0 0 0
Totale 3.365